{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-23-000083","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2023-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.820982+00:00","generated_at":"2026-06-08T22:52:03.756700+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cardinal Health Q1 revenue +10% to $54.8B; raises FY24 non-GAAP EPS guidance to $6.75-$7.00","bullets":["GAAP operating loss $14M due to $581M Medical goodwill impairment; GAAP diluted EPS $0.02.","Non-GAAP operating earnings $571M (+35%); non-GAAP diluted EPS $1.73 (+44%) vs. $1.20.","Pharmaceutical segment profit $507M (+18%); Medical segment profit $71M vs. ($8M) loss.","FY2024 non-GAAP EPS guidance raised to $6.75-$7.00 from $6.50-$6.75; pharma profit growth outlook raised to 7%-9%.","Interest and other expense guidance reduced to $100M-$120M; diluted shares ~249M."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-23-000083","json":"https://secwatch.observer/filing/0000721371-23-000083.json","markdown":"https://secwatch.observer/filing/0000721371-23-000083.md","text":"https://secwatch.observer/filing/0000721371-23-000083.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000083/0000721371-23-000083-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000083/cah-20231103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T22:52:03.756700+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dc39657139c53ffae04b292e5c0da59069939e5b","claim":"CARDINAL HEALTH INC reported the quarter ended September 30, 2023 results: revenue $54.8 billion, net income $5 million, EPS $0.02. Guidance raised.","evidence_excerpt":"report. --- EX-99.1 (EX-99.1) --- FOR IMMEDIATE RELEASE Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook • Revenue increased 10% to $54.8 billion • GAAP 1 operating loss was $14 million and GAAP diluted EPS was $0.02, driven by a Medical segment goodwill impairment • Non-GAAP operating earnings increased 35% to $571","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000083/0000721371-23-000083-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Revenue","value":"$54.8 billion"},{"label":"Net income","value":"$5 million"},{"label":"EPS","value":"$0.02"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}